Table 3.
Description of 44 cases of histoplasmosis in African children (1950–2021).
Sex/age (years) | Hcc/Hcd | Setting | HIV | Site of infection | DH | Treatment | Ocm | References |
---|---|---|---|---|---|---|---|---|
Zaire | ||||||||
a F/4 | NR | NS | N | Liver, spleen, lymph nodes | YES | Ketoconazole | F | Lamey and Parisien 22 |
Uganda | ||||||||
b M/4 | Hcc | NS | N | Mucosa | NO | Surgery/Itraconazole | F | Kweyamba et al. 23 |
Tanzania | ||||||||
c M/15 | Hcc | NS | N | Lungs | NO | None | D | Kabangila et al. 24 |
South Africa | ||||||||
F/16 | Hcc | NS | N | Bones | NO | NR | NR | Suleman and Scheepers 25 |
d M/7 | Hcc | Rural | N | Lymph nodes, spleen | YES | AmB, Ketoconazole, Itraconazole | F | Daubenton and Beatty 26 |
F/8 | Hcc | NS | P | Skin, lymph nodes, tongue | YES | None | D | Pillay et al. 27 |
F/11 | Hcc | NS | P | Skin, lung, lymph nodes, liver, spleen | YES | AmB | NR | Mosam et al. 13 |
Nigeria | ||||||||
M/6 | Hcd | NS | N | Skin, muscles, lymph nodes, bones | NO | AmB/Ketoconazole | F | Akpuaka et al. 28 |
b M/11 | NR | NS | N | Skin, muscles | NO | AmB/ketoconazole | F | Akpuaka et al. 28 |
M/10 | Hcd | NS | N | Skin, lymph nodes, bone | NO | Fluconazole | F | Onwuasoigwe 29 |
M/12 | Hcd | NS | N | Bone | NO | AmB | F | Mace 15 |
M/9 | Hcd | NS | N | Skin, bone | NO | NR | NR | Khalil et al. 12 |
M/14 | Hcd | NS | N | Lymph node | NO | NR | NR | Khalil et al. 12 |
M/9 | Hcd | NS | N | Skin, muscles | NO | Surgery/Itraconazole | F | Katchy et al. 30 |
M/13 | Hcd | NS | N | Skull | NO | AmB | F | Shoroye and Oyedeji 16 |
F/13 | Hcd | NS | N | Skin, lymph nodes | YES | None | D | Ubesie et al. 14 |
Mali | ||||||||
M/6 | Hcd | Rural | N | Skin, mucosa, lymph nodes, bones | YES | Ketoconazole | F | Minta et al. 31 |
Kenya | ||||||||
F/6 | Hcc | NS | P | Liver, spleen | YES | NR | NR | Pamnani et al. 11 |
F/1.9 | Hcc | NS | N | Liver, spleen | YES | NR | NR | Pamnani et al. 11 |
Guinea Bissau | ||||||||
M/12 | Hcd | NS | N | Skin, muscles, fistulas | NO | Posaconazole | F | Gonçalves et al. 32 |
e F/7 | NR | NS | N | Skin, muscle, bone | NO | NR | NR | Guimarães et al. 20 |
Gambia | ||||||||
F/4 | Hcd | NS | N | Skin, bone | YES | AmB/Ketoconazole | F | Mabey and Hay 33 |
F/5 | Hcd | NS | N | Lymph node | YES | AmB/Ketoconazole | F | Mabey and Hay 33 |
M/10 | Hcd | NS | N | Skin | YES | Surgery/AmB/Ketoconazole | F | Mabey and Hay 33 |
Cote d′voire | ||||||||
M/6 | Hcd | NS | N | Skin, bone | NO | Terbinafine | F | Bankolé et al. 34 |
Congo | ||||||||
M/17 | Hcd | Urban | N | Skin, bone lesions | YES | AmB | F | N’Golet et al. 35 |
F/15 | Hcd | Rural | N | Skin | NR | NR | NR | Destombes et al. 36 |
F/6 | Hcd | Rural | N | Skin | NR | AmB | F | Carme et al. 37 |
F/13 | Hcd | Rural | N | Mucosa, bone | NO | AmB | F | Carme et al. 37 |
M/11 | Hcd | Urban | N | Skin, bone | YES | AmB | F | Griffet et al. 38 |
F/2 | Hcd | NS | N | Skin, bone, eye | YES | AmB | F | Carme et al. 37 |
M/13 | Hcd | NS | N | Skin, bone | YES | AmB | F | Carme et al. 37 |
M/17 | Hcd | NS | N | Skin | NO | AmB | F | Carme et al. 37 |
M/17 | Hcd | NS | N | Skin, mucosa | NO | AmB | F | Carme et al. 37 |
M/13 | Hcd | Rural | N | Bone | YES | AmB | F | Moyikoua et al. 39 |
F/7 | Hcd | Urban | N | Skin, bone | YES | Surgery/Itraconazole | F | Paugam et al. 40 |
M/15 | Hcd | Urban | N | Skin, lung | YES | None | D | Okoko et al. 41 |
M/4 | Hcd | Urban | N | Skin, lymph nodes | YES | Itraconazole | D | Chandenier et al. 42 |
F/9 | Hcd | Urban | N | Lymph node, liver, spleen | YES | Ketoconazole | D | Mabiala et al. 43 |
M/3 | Hcd | Urban | N | Skin, lymph node, bone | YES | Itraconazole | D | Mabiala et al. 43 |
M/4 | Hcd | Urban | N | Bone lesions | YES | Itraconazole | D | Mabiala et al. 43 |
Chad | ||||||||
F/10 | Hcd | NS | N | Skin | YES | AmB | F | Garcia-Guiñon et al. 44 |
Cameroon | ||||||||
f F/12 | Hcd | NS | N | Skin, lymph nodes, bone lesions | YES | NR | NR | André et al. 45 |
Burkina Faso | ||||||||
M/1 | Hcd | Urban | N | Skin, liver, spleen, lymph nodes, bones | YES | Fluconazole/AmB | F | Barro/Traoré et al. 46 |
AmB, amphotericin B; D, death; DH, disseminated histoplasmosis; EPH, extrapulmonary histoplasmosis; F, favorable clinical outcome; F, female; Hcc, Histoplasma capsulatum; Hcd, Histoplasma duboisii; M, male; N, negative; NR, not revealed; NS, not specified; Ocm, outcome; P, positive; PH, pulmonary histoplasmosis.
Patient recovered but died of measles.
Case reports with underlying conditions (mesenteric chylous cyst, malnutrition).
A case report of pulmonary histoplasmosis in a 15-year-old male involved in crushing stones for 2 years.
Paediatric histoplasmosis reported in London in an indigene of South Africa.
Paediatric histoplasmosis reported in Portugal in an indigene of Guinea Bissau.
Paediatric histoplasmosis reported in France in an indigene of Cameroon.